Is fluoroquinolone monotherapy a useful alternative treatment for Pseudomonas aeruginosa bacteraemia

Purpose Pseudomonas aeruginosa bacteraemia is associated with high mortality, and most monotherapies are beta-lactam-based. We aimed to investigate clinical outcomes of definitive fluoroquinolone monotherapy versus beta-lactam monotherapy for P. aeruginosa bacteraemia.